Resistome and pathogenomics of multidrug resistant (MDR) Pseudomonas aeruginosa VRFPA03, VRFPA05 recovered from alkaline chemical keratitis and post-operative endophthalmitis patient

Gene

Volumn 578, Issue 1, 2016, Pages 105-111

  Murugan, Nandagopal ^a,b   Malathi, Jambulingam ^a   Umashankar, Vetrivel ^a   Madhavan, Hajib NarahariRao ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b SASTRA UNIVERSITY   (India)

Author keywords

Exotoxins; Genomics; Integrons; Multidrug efflux pump genes; Multilocus sequence typing; Pseudomonas aeruginosa; Virulence factors

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COLISTIN; ELASTASE; ELASTASE B; EXOENZYME S; EXOENZYME T; EXOENZYME Y; EXOTOXIN A; GENOMIC DNA; GENTAMICIN; IMIPENEM; MEROPENEM; METHYLTRANSFERASE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PSEUDOMONAS EXOTOXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL KERATITIS; BACTERIOPHAGE; CHEMICAL INJURY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COMPUTER MODEL; CORNEA; ENDOPHTHALMITIS; ENZYME ANALYSIS; EYE INJURY; GENE CASSETTE; GENOMICS; HUMAN; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHAGEOMICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; VITREOUS BODY; ZYMOGRAPHY; CATARACT EXTRACTION; CLASSIFICATION; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; KERATITIS; MICROBIOLOGY; PATHOGENICITY; PSEUDOMONAS INFECTIONS;

CATARACT EXTRACTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDOPHTHALMITIS; GENOME, BACTERIAL; HUMANS; KERATITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA; VIRULENCE FACTORS;

EID: 84955330648     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.12.022     Document Type: Article

References (37)

1. Aloush V., Navon-Venezia S., Seigman-Igra Y., Cabili S., Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents Chemother. 2006, 50:43-48.
2. Anon. CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res. 2007.
3. Aziz R.K., et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 2008, 75.
4. Bleves S., Viarre V., Salacha R., Michel G.P., Filloux A., Voulhoux R. Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int. J. Med. Microbiol. 2010, 300:534-543.
5. Bonomo R.A., Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. 2006, 43:S49-S56.
6. Engel J.N. Molecular pathogenesis of acute Pseudomonas aeruginosa infections. Severe Infections Caused by Pseudomonas aeruginosa 2003, 201-229. Kluwer Academic Publsihers, Dordrecht. A.R. Hauser, J. Rello (Eds.).
7. Gawish A.A., Mohammed N.A., El-Shennawy G.A., Mohammed H.A. An investigation of type 3 secretion toxins encoding-genes of Pseudomonas aeruginosa isolates in a university hospital in Egypt. J. Microbiol. Infect. Dis. 2013, 3.
8. Girlich D., Naas T., Nordmann P. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2004, 48:2043-2048.
9. Gomaa A.A., Klumpe H.E., Luo M.L., Selle K., Barrangou R., Beisel C.L. Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. mBio. 2014, 5. (e00928-13).
10. Kadlec K., Michael G.B., Sweeney M.T., Brzuszkiewicz E., Liesegang H., Daniel R., Schwarz S. Molecular basis of macrolide, triamilide, and lincosamide resistance in Pasteurella multocida from bovine respiratory disease. Antimicrob. Agents Chemother. 2011, 55:2475-2477.
11. Larsen M.V., Cosentino S., et al. Multilocus sequence typing of total genome sequenced bacteria. J. Clin. Micobiol. 2012, 50:1355-1361.
12. Lee S., Yen M.T. Management of preseptal and orbital cellulitis. Saudi J. Ophthalmol. 2011, 25:21-29.
13. Lee D.G., Urbach J.M., Wu G., Liberati N.T., Feinbaum R.L., Miyata S., Ausubel F.M. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 2006, 7:R90.
14. Li X.Z., Livermore D.M., Nikaido H. Role of efflux pump (s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 1994, 38:1732-1741.
15. Malathi J., Murugan N., Umashankar V., Bagyalakshmi R., Madhavan H.N.R. Draft genome sequence of multidrug-resistant Pseudomonas aeruginosa strain VRFPA02, isolated from a septicemic patient in India. Genome Announc. 2013, 1. (e00425-13). 10.1128/genomeA.00425-13.
16. Marquart M.E., O'Callaghan R.J. Infectious keratitis: secreted bacterial proteins that mediate corneal damage. J. Ophthalmol 2013.
17. Murugan N., Malathi J., Umashankar V., Madhavan H.N.R. Comparative genomic analysis of multidrug-resistant Pseudomonas aeruginosa clinical isolates VRFPA06 and VRFPA08 with VRFPA07. Genome Announc. 2014, 2.
18. Murugan N., Malathi J., Umashankar V., Madhavan H.N.R. Comparative genomic analysis of multidrug-resistant Pseudomonas aeruginosa clinical isolates VRFPA06 and VRFPA08 with VRFPA07. Genome Announc. 2014, 2. (e00140-14). 10.1128/genomeA.00140-14.
19. Murugan N., Malathi J., Therese K.L., Madhavan H.N. Antimicrobial susceptibility and prevalence of extended spectrum betalactamase (ESBL) and metallo betalactamase (MBL) and its co-existence among Pseudomonas aeruginosa recovered from ocular infections. Int. J. Pharm. Pharm. Sci. 2015.
20. Murugan N., Malathi J., Umashankar V., Madhavan H.N. First Complete Genome Sequence of Ocular Isolate Carrying blaVim-2 mediated multidrug-resistant (MDR) Pseudomonas aeruginosa VRFPA04 from India and Two Draft genome Sequence of Ocular Isolates Pseudomonas aeruginosa VRFPA03 and VRFPA05. Int. J. Pharm. Pharm. Sci. 2015.
21. Partridge S.R., Tsafnat G., Coiera E., Iredell J.R. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol. Rev. 2009, 33:757-784.
22. Piddock L.J. Multidrug-resistance efflux pumps? Not just for resistance. Nat. Rev. Microbiol. 2006, 4:629-636.
23. Pillar C.M., Hobden J.A. Pseudomonas aeruginosa exotoxin A and keratitis in mice. Invest. Ophthalmol. Vis. Sci. 2002, 43:1437-1444.
24. Poirel L., Brinas L., Fortineau N., Nordmann P. Integron-encoded GES-type extended-spectrum β-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2005, 49:3593-3597.
25. Poirel L., Rodríguez-Martínez J.M., Al Naiemi N., Debets-Ossenkopp Y.J., Nordmann P. Characterization of DIM-1, an integron-encoded metallo-β-lactamase from a Pseudomonas stutzeri clinical isolate in The Netherlands. Antimicrob. Agents Chemother. 2010, 54:2420-2424.
26. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2005, 49:479-487.
27. Singh B., Röhm K.-H. Characterization of a Pseudomonas putida ABC transporter (AatJMQP) required for acidic amino acid uptake: biochemical properties and regulation by the Aau two-component system. Microbiology 2008, 797-809.
28. Sivasankar S., Lavanya R., Brindha P., Angayarkanni N. Aqueous and alcoholic extracts of Triphala and their active compounds chebulagic acid and chebulinic acid prevented epithelial to mesenchymal transition in retinal pigment epithelial cells, by inhibiting SMAD-3 phosphorylation. PloS One 2015, 10.
29. Skurnik D., et al. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc. Natl. Acad. Sci. 2013, 20747-20752.
30. Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J., Olson M.V. Complete genome sequence of pseudomonas eruginosa PAO1, an opportunistic pathogen. Nature 2001, 406:959-964.
31. Tsafnat G., Copty J., Partridge S.R. RAC: repository of antibiotic resistance cassettes. Database 2011.
32. Wang J., Liu J.H. Mutations in the chloramphenicol acetyltransferase (S61G, Y105C) increase accumulated amounts and resistance in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2004, 236:197-204.
33. Xu Z., Li L., Shirtliff M.E., Alam M.J., Yamasaki S., Shi L. Occurrence and characteristics of class 1 and 2 integrons in Pseudomonas aeruginosa isolates from patients in Southern China. J. Clin. Microbiol. 2009, 47:230-234.
34. Zankari E., Hasman H., Cosentino S., et al. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012, 67:2640-2644.
35. Zhou Y., Liang Y., Lynch K.H., Dennis J.J., Wishart D.S. PHAST: a fast phage search tool. Nucleic Acids Res 2011.
36. Zhou H., Zhang T., Yu D., Pi B., Yang Q., Zhou J., Yu Y. Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob. Agents Chemother. 2011, 55:4506-4512.
37. Zhu H., Conibear T.C.R., Bandara R., Aliwarga Y., Stapleton F., Willcox M.D.P. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr. Eye Res. 2006, 31:297-306.